DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1064015
Title:
Analysis of Gastric Adenocarcinoma Data in a Pan-GI Context to Reveal Genes, Pathways, and Interactions that Yield Novel Therapeutic Advantages
Descriptive Note:
[Technical Report, Annual Report]
Corporate Author:
The University of Texas MD Anderson Cancer Center
Report Date:
2018-09-01
Pagination or Media Count:
14
Abstract:
The subject of this research is the study of gastric cancer, where the purpose is to reveal new insights into the biology of the disease that could potentially have therapeutic implications. Specifically, the scope of the study is based on 3 broad objectives i identification of dysregulated and susceptible pathways, as well as their novel inter-relationships, in gastric adenocarcinoma GAC ii Pan-Cancer comparison of GAC with other cancers to leverage therapeutic target information across cancers iii Identification of novel therapeutic targets, both with and without currently known drugs that target them. We have identified novel interactions amongst pathways in stomach and other cancers, where we have identified certain sub-groups of stomach cancer patients where those pathways may be exceptionally abnormal and lead to worse survival. The interactions and corresponding sets of genes may be targetable by existing drugs andor drugs under development for treatment of that subgroup of stomach cancer patients. Other sub-groups have other interactions and genes that may also be targeted using different drugs. In that way, we can potentially give customized regimens of drugs to specific patients whose cancers exhibit targetable characteristics.
Distribution Statement:
[A, Approved For Public Release]
